SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,875,492 | -77.8% | 788,022 | -55.2% | 0.00% | -75.0% |
Q2 2023 | $8,429,988 | +363889.1% | 1,759,914 | +330.8% | 0.00% | +300.0% |
Q1 2023 | $2,316 | +101.2% | 408,480 | +98.8% | 0.00% | 0.0% |
Q4 2022 | $1,151 | -100.0% | 205,472 | -81.2% | 0.00% | -50.0% |
Q2 2022 | $3,752,000 | -10.6% | 1,093,910 | +85.6% | 0.00% | 0.0% |
Q1 2022 | $4,196,000 | -60.2% | 589,286 | -53.4% | 0.00% | -60.0% |
Q4 2021 | $10,533,000 | +425.3% | 1,264,486 | +338.9% | 0.01% | +400.0% |
Q3 2021 | $2,005,000 | -78.3% | 288,118 | -25.7% | 0.00% | -83.3% |
Q2 2021 | $9,243,000 | +68.1% | 387,547 | +45.1% | 0.01% | +50.0% |
Q1 2021 | $5,500,000 | -29.1% | 267,121 | -15.7% | 0.00% | -33.3% |
Q4 2020 | $7,760,000 | -2.8% | 316,749 | +12.4% | 0.01% | -40.0% |
Q3 2020 | $7,980,000 | +352.9% | 281,875 | -23.9% | 0.01% | +400.0% |
Q2 2020 | $1,762,000 | +70.1% | 370,256 | +15.0% | 0.00% | 0.0% |
Q2 2019 | $1,036,000 | -48.2% | 321,856 | +10.5% | 0.00% | -33.3% |
Q1 2019 | $2,001,000 | +1686.6% | 291,290 | +1874.4% | 0.00% | – |
Q3 2018 | $112,000 | -92.4% | 14,753 | -91.4% | 0.00% | -100.0% |
Q2 2018 | $1,481,000 | +135.1% | 172,173 | +100.6% | 0.00% | +100.0% |
Q1 2018 | $630,000 | -79.0% | 85,825 | -71.0% | 0.00% | -75.0% |
Q4 2017 | $2,998,000 | -11.3% | 295,675 | +40.3% | 0.00% | -20.0% |
Q3 2017 | $3,380,000 | +39.6% | 210,739 | -1.7% | 0.01% | 0.0% |
Q2 2017 | $2,422,000 | -2.6% | 214,359 | -2.9% | 0.01% | 0.0% |
Q1 2017 | $2,487,000 | +11.7% | 220,662 | -1.9% | 0.01% | 0.0% |
Q4 2016 | $2,227,000 | +780.2% | 224,927 | +2261.4% | 0.01% | +400.0% |
Q1 2016 | $253,000 | -95.9% | 9,525 | -94.6% | 0.00% | -92.3% |
Q4 2015 | $6,158,000 | +101.2% | 175,503 | +70.0% | 0.01% | +116.7% |
Q3 2015 | $3,060,000 | -11.1% | 103,253 | +24.5% | 0.01% | -14.3% |
Q2 2015 | $3,442,000 | – | 82,931 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |